Relay Therapeutics Inc. (RLAY): Price and Financial Metrics
RLAY Price/Volume Stats
| Current price | $4.26 | 52-week high | $12.14 |
| Prev. close | $4.20 | 52-week low | $4.11 |
| Day low | $4.12 | Volume | 1,966,800 |
| Day high | $4.32 | Avg. volume | 1,549,838 |
| 50-day MA | $5.47 | Dividend yield | N/A |
| 200-day MA | $6.81 | Market Cap | 713.05M |
RLAY Stock Price Chart Interactive Chart >
Relay Therapeutics Inc. (RLAY) Company Bio
Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
RLAY Price Returns
| 1-mo | -8.58% |
| 3-mo | -43.20% |
| 6-mo | -38.62% |
| 1-year | -60.41% |
| 3-year | -86.29% |
| 5-year | N/A |
| YTD | -61.31% |
| 2023 | -26.31% |
| 2022 | -51.35% |
| 2021 | -26.11% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...